obesity drug news today october 2025 glp-1 27 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 Weight-Loss Drug Demonstration Begins – The GLP-1 Access Gap: Mapping

B., Neogi, T., da Rocha Castelar-Pinheiro, G., Kapetanovic, M

Key data point: in the retatrutide fatty-liver study, Sanyal and colleagues (Nature Medicine, 2024) reported liver fat falling 80 to 90 percent over 48 weeks in patients who started with fatty liver disease, a drop tied closely to the weight and belly-fat loss and, in theory, to glucagon-receptor-driven fat burning in the liver

1.30.19 15mins said: Please read the discussion above about licorice root, its an ingredient more OBs are feeling nervous about so Ive included it in my list

Storage Storage & Stability BPC-157 is tougher than most peptides its gastric acid resistance gives it an edge in stability

This decline contributes to many age-related changes like decreased muscle mass, increased body fat, reduced bone density, and lower energy levels